Provided by Tiger Trade Technology Pte. Ltd.

BEONE MEDICINES

215.400
-9.000-4.01%
Volume:5.34M
Turnover:1.15B
Market Cap:332.15B
PE:144.63
High:219.400
Open:215.000
Low:212.200
Close:224.400
52wk High:235.600
52wk Low:153.000
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:1.75
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.489
ROE:14.66%
ROA:7.46%
PB:8.19
PE(LYR):144.63
PS:6.91

Loading ...

CICC Retains Outperform Rating on BeiGene (06160) with HKD 266 Price Target

Stock News
·
Aug 11

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

Stock News
·
Aug 11

Movement Alert|BEONE MEDICINES Intraday Rise 3.94% in Regular Trading, Clinical Collaboration with Revolution Medicines on RAS Combination Therapies

Market Focus
·
Aug 11

BOCOM International Lifts BEONE MEDICINES Price Target to HKD 276, Maintains Buy Rating

Stock News
·
Aug 10

Movement Alert|BEONE MEDICINES Rises 3.05% in Regular Trading, Q2 Earnings Massively Beat Expectations as Multiple Banks Raise Target Prices

Market Focus
·
Aug 10

Goldman Sachs Competitor Adjusts BeOne Medicines Target Upward, Bullish Ratings Maintained

Deep News
·
Aug 09

BEONE MEDICINES Confirms External CMO Supply for Baiyueda, All Processes On Schedule

Deep News
·
Aug 07

BEONE MEDICINES: Approximately 95% of Pancreatic Cancer Cases Show KRAS Mutation, Around 20% Exhibit MTAP Deletion, Enabling Easy Identification of Overlapping Patient Groups

Deep News
·
Aug 07

BEONE MEDICINES Reports BRUKINSA Captures Over Half of New CLL/SLL Patient Share

Deep News
·
Aug 07

Beigene's GPC3x4-1BB Candidate Moves From Phase 1 to a Potential Pivotal Phase 2 Study in About 19 Months

Deep News
·
Aug 07

BEONE MEDICINES Halts Initial KRAS Inhibitor Project but Remains Active in RAS Field

Deep News
·
Aug 07

BEONE MEDICINES Plans to Unveil Preliminary CEA ADC Findings for Non-Small Cell Lung Cancer, Including Both Squamous and Non-Squamous Cases

Deep News
·
Aug 07

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

Stock News
·
Aug 07

CLSA Maintains Outperform Rating on BEONE MEDICINES, Raises Price Target to HK$321.70

Deep News
·
Aug 07

BEONE MEDICINES Surges Over 4% Intraday as UOB Kay Hian Raises Target Price to HK$265

Deep News
·
Aug 07

Hong Kong Stock Moves: BEONE MEDICINES Surges Nearly 4% After Earnings, Adjusted Net Profit Up 111% YoY in First Half, Solid Tumor Progress Noted

Stock News
·
Aug 07

Movement Alert|BEONE MEDICINES Rises 3.16% in Regular Trading, Q2 Earnings Massively Beat Expectations as Multiple Banks Raise Target Prices

Market Focus
·
Aug 07

BeOne Medicines HK Shares Climb on Q2 Revenue Growth, Outlook Optimism

Reuters
·
Aug 06

Interim Net Profit Surges 627%, Full-Year Revenue Guidance Raised: Beone Medicines Rebounds on Hong Kong Exchange, Huabao's Innovative Drug ETF Sees Premium Trading

Deep News
·
Aug 06

BeOne Medicines Posts 627% Jump in H1 Profit; Shares Fall 5%

MT Newswires Live
·
Aug 06